Acknowledgement
This research was funded by the KIOM of South Korea, grant number KSN2012330.
References
- Zhang S, Wang Y, Cheng K, Huangfu N, Zhao R, Xu Z, Zhang F, Zheng W, Zhang D. Hyperuricemia and cardiovascular disease. Curr Pharm Des 2019;25:700-9. https://doi.org/10.2174/1381612825666190408122557
- Su J, Wei Y, Liu M, Liu T, Li J, Ji Y, Liang J. Anti-hyperuricemic and nephroprotective effects of Rhizoma Dioscoreae septemlobae extracts and its main component dioscin via regulation of mOAT1, mURAT1 and mOCT2 in hypertensive mice. Arch Pharm Res 2014;37:1336-44. https://doi.org/10.1007/s12272-014-0413-6
- Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol 2011;23:192-202. https://doi.org/10.1097/bor.0b013e3283438e13
- Wang R, Ma CH, Zhou F, Kong LD. Siwu decoction attenuates oxonate-induced hyperuricemia and kidney inflammation in mice. Chin J Nat Med 2016;14:499-507. https://doi.org/10.1016/S1875-5364(16)30059-0
- Wu AH, Gladden JD, Ahmed M, Ahmed A, Filippatos G. Relation of serum uric acid to cardiovascular disease. Int J Cardiol 2016;213:4-7. https://doi.org/10.1016/j.ijcard.2015.08.110
- Benn CL, Dua P, Gurrell R, Loudon P, Pike A, Storer RI, Vangjeli C. Physiology of hyperuricemia and urate-lowering treatments. Front Med (Lausanne) 2018;5:160. https://doi.org/10.3389/fmed.2018.00160
- Chen C, Lu JM, Yao Q. Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview. Med Sci Monit 2016;22:2501-12. https://doi.org/10.12659/msm.899852
- Chohan S. Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions. J Rheumatol 2011;38:1957-9. https://doi.org/10.3899/jrheum.110092
- Strilchuk L, Fogacci F, Cicero AF. Safety and tolerability of available urate-lowering drugs: a critical review. Expert Opin Drug Saf 2019;18:261-71. https://doi.org/10.1080/14740338.2019.1594771
- Jeong MY, Park DH, Kim MC, Park J, Kim DS, Jeon YD, Kim SJ, Ahn KS, Kim SH, Lee JH, et al. Saengmaeksan inhibits inflammatory mediators by suppressing RIP-2/caspase-1 activation. Immunopharmacol Immunotoxicol 2013;35:241-50. https://doi.org/10.3109/08923973.2012.757617
- Park KJ, Lee MJ, Kang H, Kim KS, Lee SH, Cho I, Lee HH. Saeng-Maek-San, a medicinal herb complex, protects liver cell damage induced by alcohol. Biol Pharm Bull 2002;25:1451-5. https://doi.org/10.1248/bpb.25.1451
- Lee D, Lee J, Vu-Huynh KL, Van Le TH, Tuoi Do TH, Hwang GS, Park JH, Kang KS, Nguyen MD, Yamabe N. Protective effect of panaxynol isolated from Panax vietnamensis against cisplatin-induced renal damage: in vitro and in vivo studies. Biomolecules 2019 Dec 17;9(12):890.
- Lee YK, Chin YW, Choi YH. Effects of Korean red ginseng extract on acute renal failure induced by gentamicin and pharmacokinetic changes by metformin in rats. Food Chem Toxicol 2013;59:153-9. https://doi.org/10.1016/j.fct.2013.05.025
- Li YZ, Ren S, Yan XT, Li HP, Li W, Zheng B, Wang Z, Liu YY. Improvement of Cisplatin-induced renal dysfunction by Schisandra chinensis stems via anti-inflammation and anti-apoptosis effects. J Ethnopharmacol 2018;217:228-37. https://doi.org/10.1016/j.jep.2018.01.033
- Zhu P, Li J, Fu X, Yu Z. Schisandra fruits for the management of drug-induced liver injury in China: a review. Phytomedicine 2019;59:152760. https://doi.org/10.1016/j.phymed.2018.11.020
- Kim MJ, Yoo YC, Sung NY, Lee J, Park SR, Shon EJ, Lee BD, Kim MR. Anti-inflammatory effects of Liriope platyphylla in LPS-stimulated macrophages and endotoxemic mice. Am J Chin Med 2016;44:1127-43. https://doi.org/10.1142/s0192415x16500634
- Xiao ZQ, Wang YL, Yue YD, Zhang YT, Chen CP, Wan LS, Deng B, Liu ZX, Chen JC. Preventive effects of polysaccharides from Liriope spicata var. prolifera on diabetic nephropathy in rats. Int J Biol Macromol 2013;61:114-20. https://doi.org/10.1016/j.ijbiomac.2013.06.047
- Wang X, Wang CP, Hu QH, Lv YZ, Zhang X, Ouyang Z, Kong LD. The dual actions of sanmiao wan as a hypouricemic agent: down-regulation of hepatic XOD and renal mURAT1 in hyperuricemic mice. J Ethnopharmacol 2010;128:107-15. https://doi.org/10.1016/j.jep.2009.12.035
- Viazzi F, Leoncini G, Ratto E, Pontremoli R. Hyperuricemia and renal risk. High Blood Press Cardiovasc Prev 2014;21:189-94. https://doi.org/10.1007/s40292-014-0042-7
- Tang DH, Ye YS, Wang CY, Li ZL, Zheng H, Ma KL. Potassium oxonate induces acute hyperuricemia in the tree shrew (tupaia belangeri chinensis). Exp Anim 2017;66:209-16. https://doi.org/10.1538/expanim.16-0096
- Lee YS, Kim SH, Yuk HJ, Kim DS. DKB114, a mixture of Chrysanthemum indicum Linne flower and Cinnamomum cassia (L.) J. Presl bark extracts, improves hyperuricemia through inhibition of xanthine oxidase activity and increasing urine excretion. Nutrients 2018;10:1381. https://doi.org/10.3390/nu10101381
- Qin Z, Wang S, Lin Y, Zhao Y, Yang S, Song J, Xie T, Tian J, Wu S, Du G. Antihyperuricemic effect of mangiferin aglycon derivative J99745 by inhibiting xanthine oxidase activity and urate transporter 1 expression in mice. Acta Pharm Sin B 2018;8:306-15. https://doi.org/10.1016/j.apsb.2017.05.004
- Lee JW, Choi BR, Kim YC, Choi DJ, Lee YS, Kim GS, Baek NI, Kim SY, Lee DY. Comprehensive profiling and quantification of ginsenosides in the root, stem, leaf, and berry of Panax ginseng by UPLC-QTOF/MS. Molecules 2017;22:2147. https://doi.org/10.3390/molecules22122147
- Zhang HM, Li SL, Zhang H, Wang Y, Zhao ZL, Chen SL, Xu HX. Holistic quality evaluation of commercial white and red ginseng using a UPLC-QTOF-MS/MS-based metabolomics approach. J Pharm Biomed Anal 2012;62:258-73. https://doi.org/10.1016/j.jpba.2012.01.010
- Bove M, Cicero AF, Veronesi M, Borghi C. An evidence-based review on uratelowering treatments: implications for optimal treatment of chronic hyperuricemia. Vasc Health Risk Manag 2017;13:23-8. https://doi.org/10.2147/VHRM.S115080
- Lipkowitz MS. Regulation of uric acid excretion by the kidney. Curr Rheumatol Rep 2012;14:179-88. https://doi.org/10.1007/s11926-012-0240-z
- Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol 2016;213:8-14. https://doi.org/10.1016/j.ijcard.2015.08.109
- Matsuo H, Nakayama A, Sakiyama M, Chiba T, Shimizu S, Kawamura Y, Nakashima H, Nakamura T, Takada Y, Oikawa Y, et al. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload. Sci Rep 2014;4:3755. https://doi.org/10.1038/srep03755
- Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T, Yamanashi Y, Kasuga H, Nakashima H, Nakamura T, et al. Decreased extrarenal urate excretion is a common cause of hyperuricemia. Nat Commun 2012;3:764. https://doi.org/10.1038/ncomms1756
- Bao R, Liu M, Wang D, Wen S, Yu H, Zhong Y, Li Z, Zhang Y, Wang T. Effect of Eurycoma longifolia stem extract on uric acid excretion in hyperuricemia mice. Front Pharmacol 2019;10:1464. https://doi.org/10.3389/fphar.2019.01464
- Yousef MI, Hussien HM. Cisplatin-induced renal toxicity via tumor necrosis factor-a, interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: protective effect of ginseng. Food Chem Toxicol 2015;78:17-25. https://doi.org/10.1016/j.fct.2015.01.014
- Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999:581685-93.
- Baek SH, Shin BK, Kim NJ, Chang SY, Park JH. Protective effect of ginsenosides Rk3 and Rh4 on cisplatin-induced acute kidney injury in vitro and in vivo. J Ginseng Res 2017;41:233-9. https://doi.org/10.1016/j.jgr.2016.03.008
- Zhang Y, Su H, Zhang J, Kong J. The effects of ginsenosides and anserine on the up-regulation of renal aquaporins 1-4 in hyperuricemic mice. Am J Chin Med 2019;47:1133-47. https://doi.org/10.1142/s0192415x19500587